Brightsurf Science News and Current Science News Events

 
Email a Friend Send to a friend
Printer Friendly Print Low-intensity case management cuts COPD-related hospital visits in half

Low-intensity case management cuts COPD-related hospital visits in half

May 21, 2008

A new study has found that patients with chronic obstructive pulmonary disease (COPD) who are at high risk for hospitalization or emergency room visits from exacerbations or complications benefit from simple low-intensity case management.

"While a model of intensive case management for COPD was previously shown to reduce hospitalizations for COPD, until now there has been little evidence that a more limited intervention model is effective," said Kathryn Rice, M.D., staff physician in the Pulmonary Division of Minneapolis Veterans Affairs Hospital and associate professor of medicine at the University of Minnesota, who will present her findings at the American Thoracic Society's 2008 International Conference in Toronto on Wednesday, May 21.




Dr. Rice and co-principal investigator Naresh Dewan, M.D., of Omaha VA Medical Center and Creighton University, prospectively enrolled 743 patients at five VA hospitals and randomized them to receive limited case-management or conventional care from their primary care provider according to local practice. Those randomized to case management received an hour of clinical assessment and education in a group setting, personalized adjustment of their medications according to GOLD/ATS guidelines, a written action plan that included a description of symptoms of COPD exacerbations, and refillable prescriptions for antibiotics and or short courses of prednisone to manage exacerbations with specific instructions as to when to take them, as well as monthly follow-up calls from the case manager. The case manager, a respiratory therapist, was also available for phone consultations as needed, and patients were instructed to contact the case manager whenever their action plan was implemented.

Over the year of the study, emergency room visits for COPD decreased by more than one-half and hospitalizations for COPD decreased by nearly one-third in the patients who received limited case management versus those who received traditional treatment. Hospital admissions for any causes decreased by more than 20 percent in case-managed patients.

"The limited case management model also improved measures of quality of life and was associated with a non-statistically significant reduction in mortality, although study was not a large enough to detect a definite effect on mortality" explained Dr. Rice. "Because of its relative simplicity, we believe that this model could be easily implemented across a wide variety of clinical settings. This may not only improve patient outcomes, but could also reduce the strain on hospital systems overburdened by preventable emergencies."

American Thoracic Society



Related Chronic Obstructive Pulmonary Disease News Articles Chronic Obstructive Pulmonary Disease News and Current Chronic Obstructive Pulmonary Disease Events RSS Chronic Obstructive Pulmonary Disease News and Current Chronic Obstructive Pulmonary Disease Events RSS
Smoking out the mediators of airway damage caused by pollutants
New insight into how pollution and cigarette smoke damage airways has been provided by Pierangelo Geppetti and colleagues, at the University of Florence, Italy, who studied the effects of such chemicals on guinea pig airways.

Brief, intense exercise benefits the heart
Short bursts of high intensity sprints-known to benefit muscle and improve exercise performance-can improve the function and structure of blood vessels, in particular arteries that deliver blood to our muscles and heart, according to new research from McMaster University.

COPD patients benefit more from pulmonary rehab in earlier stages
Patients with chronic obstructive pulmonary disease (COPD) who are in their final years of survival do not get the same benefits from pulmonary rehabilitation (PR) as patients who have more years left to live-regardless of their age, complicating illnesses or lung function.

Personalized therapy for asthma and COPD could soon be here
Researchers at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and treatment of patients with chronic inflammatory lung disease.

Biomarkers identified for idiopathic pulmonary fibrosis
The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month's edition of PLoS Medicine, an open-access journal of the Public Library of Science.

Excess pneumonia deaths linked to engine exhaust
Engine exhaust fumes are linked to excess deaths from pneumonia across England, suggests research published in the Journal of Epidemiology and Community Health.

Computer game helps COPD patients breathe better
Patients with chronic obstructive pulmonary disease (COPD) may gain better control over their breathing and breathe more efficiently by using their breath to play a computer game, according to new research.

UNC, Harvard develop inhaled TB vaccine
A new tuberculosis vaccine successfully tested at the University of North Carolina at Chapel Hill is easier to administer and store and just as effective as one commonly used worldwide.

Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers
Researchers at Henry Ford Hospital today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new option for those suffering with advanced emphysema.

Genetic factors in smoking also increase risk of chronic bronchitis
Smoking is a known risk factor for respiratory diseases like chronic bronchitis, but genes also play a significant role in its development, according to researchers in Sweden, who studied more than 40,000 Swedish twins to determine the extent to which behavior, environment and genes each play a role ion the development of chronic bronchitis.
More Chronic Obstructive Pulmonary Disease News Articles
Natural Therapies for Emphysema and COPD: Relief and Healing for Chronic Pulmonary Disorders
by Robert J. Green Jr.


COPD For Dummies (For Dummies (Health & Fitness))
by Kevin, MD Felner, Meg Schneider


100 Questions & Answers About COPD (100 Questions & Answers about . . .)
by Campion E. Quinn


The Chronic Bronchitis and Emphysema Handbook
by François Haas, Sheila Sperber Haas


Coping with COPD: Understanding, Treating, and Living with Chronic Obstructive Pulmonary Disease
by Elaine Fantle Shimberg


Courage and Information for Life with Chronic Obstructive Pulmonary Disease: The Handbook for Patients, Families and Care Givers Managing COPD, Emphysema, Bronchitis
by Rick Carter, Jo-Von Tucker, Thomas Petty, Brian Tiep, Richard Knowles


Adventures of an Oxy-Phile
by Thomas L. Petty


Life and Breath: Preventing, Treating and Reversing Chronic Obstructive Pulmonary Disease
by Neil Schachter


Combination Therapy for Asthma and Chronic Obstructive Pulmonary Disease (Lung Biology in Health and Disease, V. 145)


Chronic Obstructive Pulmonary Disease (Lung Biology in Health and Disease)
by Petty


© 2008 BrightSurf.com